SERUM AMYLOID A GENE EXPRESSION: A KINETIC ANALYSIS
血清淀粉样蛋白 A 基因表达:动力学分析
基本信息
- 批准号:3153868
- 负责人:
- 金额:$ 11.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-23 至 1987-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The acute phase response is a complex physiologic process consisting of
systemic, metabolic, humoral and nutritional alterations, that is set into
motion following tissue injury and cell necrosis. One such event is the
change, usually an increase, in concentration of a large number of plasma
proteins, including two inducible proteins, serum amyloid A (SAA) and
C-reactive protein (CRP). Induction of SAA synthesis has been partially
characterized as a sequence of cellular and molecular events involving
macrophage production of a circulating mediator Interleukin 1 (IL-1) which
precedes transcription of SAA mRNA and synthesis of SAA in liver. The
overall goal of this study is to define the cellular and molecular
processes regulating SAA gene expression.
The investigation will begin with studies of in vivo SAA induction in two
animal models, mice and rabbits, using two inflammatory stimuli,
lipopolysaccharide (LPS) and subcutaneous turpentine oil injection. The
goal of the in vivo studies will be to determine the sequential kinetics of
IL-1 production, of transcription of SAA mRNA, translation of SAA mRNA, and
post-translational modification of preSAA to mature apoSAA. In addition to
defining the molecular chain of events involved in hepatic SAA induction,
this proposal will study possible extrahepatic SAA synthesis. Furthermore,
the relationship between IL-1 mediated SAA induction and acute phase
induction of CRP synthesis will be studied. Using the molecular details
determined for in vivo SAA induction, the effect of IL-1 and other factors
regulating SAA synthesis will be evaluated at the cellular level in primary
cultures of liver and other SAA synthesizing tissues, with the aim of
defining those conditions necessary to mimic the in vivo situation of 1000
fold increase in SAA synthesis. At the molecular level, the regulation and
kinetics of cell-free and cellular translation of SAA mRNA will be compared
using the rabbit reticulocyte lysate system, Xenopus oocytes and primary
liver cell cultures. Finally, at the genomic level, the number and
distribution of human and mouse SAA genes will be determined and the DNA
polymorphism of SAA in normal individuals and those with secondary amyloid
will be compared. Methodology to be employed includes radioimmunoassay,
Northern and Southern DNA blot analysis, immunocytochemistry, electron
microscopy, primary cell culture and cell free protein synthesis. This
study will provide information essential to future therapeutic enhancement
of host defense following tissue injury and cell necrosis and will support
future studies of chronic inflammation, one sequence of which is the
devastating condition amyloidosis.
急性期反应是一个复杂的生理过程,包括
系统性、新陈代谢、体液和营养改变,这被设置为
组织损伤和细胞坏死后的运动。其中一个这样的事件是
大量血浆浓度的变化,通常是增加
蛋白质,包括两种诱导蛋白,血清淀粉样蛋白A(SAA)和
C反应蛋白(CRP)。对SAA合成的诱导部分是
其特征是一系列细胞和分子事件,包括
巨噬细胞产生循环介质白介素1的研究
在肝脏中SAA mRNA转录和SAA合成之前。这个
这项研究的总体目标是定义细胞和分子
调节SAA基因表达的过程。
这项研究将从两个体内诱导SAA的研究开始
动物模型,小鼠和兔子,使用两种炎症刺激,
皮下注射脂多糖和松节油。这个
体内研究的目标将是确定药物的顺序动力学。
IL-1的产生、SAA mRNA的转录、SAA mRNA的翻译以及
翻译后将前SAA修饰为成熟apoSAA。除了……之外
确定了涉及肝脏SAA诱导的事件的分子链,
这项建议将研究可能的肝外SAA合成。此外,
IL-1介导的SAA诱导与急性期的关系
对C反应蛋白的诱导合成将进行研究。使用分子细节
测定对体内SAA诱导、IL-1等因素的影响
调节SAA合成将在细胞水平上进行评估
肝脏和其他合成SAA组织的培养,目的是
定义了模拟1000的活体情况所必需的条件
SAA合成成倍增加。在分子水平上,调节和
比较SAA基因无细胞翻译和细胞翻译的动力学
用兔网织红细胞裂解液系统、非洲爪哇卵母细胞和原代
肝细胞培养。最后,在基因组水平上,数量和
人类和小鼠SAA基因的分布将被确定,DNA
正常人和继发性淀粉样变性者SAA基因的多态性
将会被比较。将采用的方法包括放射免疫分析,
Northern和Southern DNA杂交分析、免疫细胞化学、电子
显微镜、原代细胞培养和游离蛋白质合成。这
这项研究将为未来的治疗改进提供必要的信息
在组织损伤和细胞坏死后的宿主防御,并将支持
未来对慢性炎症的研究,其中一个序列是
严重的淀粉样变性。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes.
经历不同炎症发作的小鼠肝脏和腹膜巨噬细胞中淀粉样蛋白 SAA 3 基因的差异表达。
- DOI:
- 发表时间:1987
- 期刊:
- 影响因子:0
- 作者:Rokita,H;Shirahama,T;Cohen,AS;Meek,RL;Benditt,EP;Sipe,JD
- 通讯作者:Sipe,JD
Limited effects of recombinant human and murine interleukin 1 and tumour necrosis factor on production of acute phase proteins by cultured rat hepatocytes.
重组人和鼠白细胞介素 1 和肿瘤坏死因子对培养的大鼠肝细胞产生急性期蛋白的影响有限。
- DOI:
- 发表时间:1987
- 期刊:
- 影响因子:0
- 作者:Koj,A;Kurdowska,A;Magielska-Zero,D;Rokita,H;Sipe,JD;Dayer,JM;Demczuk,S;Gauldie,J
- 通讯作者:Gauldie,J
Serum amyloid A gene expression and AA amyloid formation in A/J and SJL/J mice.
A/J 和 SJL/J 小鼠血清淀粉样蛋白 A 基因表达和 AA 淀粉样蛋白形成。
- DOI:
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Rokita,H;Shirahama,T;Cohen,AS;Sipe,JD
- 通讯作者:Sipe,JD
The acute phase response in gout.
痛风的急性期反应。
- DOI:
- 发表时间:1987
- 期刊:
- 影响因子:0
- 作者:Roseff,R;Wohlgethan,JR;Sipe,JD;Canoso,JJ
- 通讯作者:Canoso,JJ
Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1.
肿瘤坏死因子/恶病素是一种比白细胞介素 1 更弱的血清淀粉样蛋白 A 合成诱导剂。
- DOI:
- 发表时间:1987
- 期刊:
- 影响因子:0
- 作者:Sipe,JD;Vogel,SN;Douches,S;Neta,R
- 通讯作者:Neta,R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jean D Sipe其他文献
Jean D Sipe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jean D Sipe', 18)}}的其他基金
CELLULAR METABOLISM OF AMYLOID PROTEINS IN AGING
衰老过程中淀粉样蛋白的细胞代谢
- 批准号:
6123293 - 财政年份:1998
- 资助金额:
$ 11.94万 - 项目类别:
CELLULAR METABOLISM OF AMYLOID PROTEINS IN AGING
衰老过程中淀粉样蛋白的细胞代谢
- 批准号:
2001329 - 财政年份:1990
- 资助金额:
$ 11.94万 - 项目类别:
CELLULAR METABOLISM OF AMYLOID PROTEINS IN AGING
衰老过程中淀粉样蛋白的细胞代谢
- 批准号:
2050531 - 财政年份:1990
- 资助金额:
$ 11.94万 - 项目类别:
CELLULAR METABOLISM OF AMYLOID PROTEINS IN AGING
衰老过程中淀粉样蛋白的细胞代谢
- 批准号:
3120814 - 财政年份:1990
- 资助金额:
$ 11.94万 - 项目类别:
CELLULAR METABOLISM OF AMYLOID PROTEINS IN AGING
衰老过程中淀粉样蛋白的细胞代谢
- 批准号:
2050534 - 财政年份:1990
- 资助金额:
$ 11.94万 - 项目类别:
CELLULAR METABOLISM OF AMYLOID PROTEINS IN AGING
衰老过程中淀粉样蛋白的细胞代谢
- 批准号:
3120817 - 财政年份:1990
- 资助金额:
$ 11.94万 - 项目类别:
CELLULAR METABOLISM OF AMYLOID PROTEINS IN AGING
衰老过程中淀粉样蛋白的细胞代谢
- 批准号:
3120816 - 财政年份:1990
- 资助金额:
$ 11.94万 - 项目类别:
CELLULAR METABOLISM OF AMYLOID PROTEINS IN AGING
衰老过程中淀粉样蛋白的细胞代谢
- 批准号:
2050533 - 财政年份:1990
- 资助金额:
$ 11.94万 - 项目类别:
相似海外基金
DETERMINANTS OF OUTCOME TO DISEASE-MODIFYING THERAPY FOR TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY
转甲状腺素蛋白淀粉样变性心肌病疾病缓解治疗结果的决定因素
- 批准号:
495435 - 财政年份:2023
- 资助金额:
$ 11.94万 - 项目类别:
21st century disease, innovative radiation therapy for amyloidosis
21世纪疾病,淀粉样变性的创新放射疗法
- 批准号:
23K07095 - 财政年份:2023
- 资助金额:
$ 11.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis
芯片磷酸化刺激突变运甲状腺素蛋白的降解以减轻心脏淀粉样变性
- 批准号:
10905158 - 财政年份:2023
- 资助金额:
$ 11.94万 - 项目类别:
Development of a method to differentiate types of cardiac amyloidosis using Raman spectroscopy.
开发一种使用拉曼光谱区分心脏淀粉样变性类型的方法。
- 批准号:
23K17233 - 财政年份:2023
- 资助金额:
$ 11.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
New Developments in Amyloidosis Research Using Cordyceps Lectin
利用冬虫夏草凝集素研究淀粉样变性的新进展
- 批准号:
23K10950 - 财政年份:2023
- 资助金额:
$ 11.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulatory mechanism of amyloidosis-like function of seminal vesicle secretory proteins in the acquisition of sperm capacitaion.
精囊分泌蛋白类淀粉样变性功能在精子获能过程中的调节机制。
- 批准号:
23K08748 - 财政年份:2023
- 资助金额:
$ 11.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aortic Stenosis and Cardiac Amyloidosis
主动脉瓣狭窄和心脏淀粉样变性
- 批准号:
23K15548 - 财政年份:2023
- 资助金额:
$ 11.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Amyloidosis Forum: Advancing Drug Development in ATTR Amyloidosis in an Evolving Treatment Landscape.
淀粉样变性论坛:在不断发展的治疗格局中推进 ATTR 淀粉样变性的药物开发。
- 批准号:
10683562 - 财政年份:2023
- 资助金额:
$ 11.94万 - 项目类别:
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
腰椎管狭窄标本分析鉴定运甲状腺素蛋白心脏淀粉样变性
- 批准号:
10637491 - 财政年份:2023
- 资助金额:
$ 11.94万 - 项目类别: